Ireland· IE-PA-EU/1/18/1272/001-002
Shingrix powder and suspension for suspension for injection. Herpes zoster vaccine (recombinant, adjuvanted).
A zoster, gereinigtes antigen product containing recombinant varicella zoster virus surface glycoprotein e, registered in Ireland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Zoster, gereinigtes antigen is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BK03 (zoster, gereinigtes antigen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Zoster, gereinigtes antigen · ATC J07BK03
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Recombinant varicella zoster virus surface glycoprotein e
- Manufacturer
- GlaxoSmithKline Biologicals S.A.
- Country
- Ireland (IE)
- ATC code
- J07BK03
- ATC class
- Zoster, gereinigtes Antigen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/18/1272/001-002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BK03
Zoster, gereinigtes antigen, as other registers publish it.
- NorwayShingrixGlaxoSmithKline Biologicals SA
- FinlandShingrixGlaxoSmithKline Biologicals SA
- DenmarkShingrixGlaxoSmithKline Biologicals
- BelgiumShingrixGlaxoSmithKline Biologicals
- PolandShingrixGlaxoSmithKline Biologicals S.A.
- IcelandShingrixGlaxoSmithKline Biologicals S.A.*
- FinlandShingrixGlaxoSmithKline Biologicals SA
- DenmarkShingrixGlaxoSmithKline Biologicals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c10fab91-e677-4a5d-b905-ec202966b387 GET /v1/drugs/c10fab91-e677-4a5d-b905-ec202966b387?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and suspension for suspension for injection",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07BK",
"J07BK03"
],
"strength": null,
"pa_number": "EU/1/18/1272/001-002",
"substances": [
"Recombinant varicella zoster virus surface glycoprotein e"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "21/03/2018",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about zoster, gereinigtes antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.